NAV
$38.74
AUM
$55.8M
Expense Ratio
-
Dividend Yield
0.00%
Beta
1.26
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +10.27% | +12.18% | +17.45% | +38.03% | +9.41% | -3.98% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | GH | Guardant Health Inc | 2.83% |
| 2 | AXGN | Axogen Inc | 2.76% |
| 3 | ARWR | Arrowhead Pharmaceuticals Inc | 2.60% |
| 4 | TWST | Twist Bioscience Corp | 2.56% |
| 5 | ILMN | Illumina Inc | 2.40% |
| 6 | GRAL | GRAIL Inc | 2.39% |
| 7 | NTRA | Natera Inc | 2.25% |
| 8 | VCYT | Veracyte Inc | 2.21% |
| 9 | NVCR | NovoCure Ltd | 2.19% |
| 10 | LIVN | LivaNova PLC | 2.17% |
The fund will normally invest at least 80% of its total assets in securities of the index or in depositary receipts representing securities of the index. The index is designed to measure the performance of companies that have a portion of their business and revenue derived from the field of healthcare technology, and the potential to grow within this space through innovation and market adoption of such companies’ products and services. It is non-diversified.
Inception Date: 2019-06-24